Oki Y - Search Results

1

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Oki Y, et al. Br J Haematol. 2014 Sep;166(6):891-901. doi: 10.1111/bjh.12982. Epub 2014 Jun 18. Br J Haematol. 2014. PMID: 24943107 Free article.

2

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Pro B, Hagemeister FB, Bleyer A, Loyer E, Younes A. Oki Y, et al. Cancer. 2005 Aug 15;104(4):781-7. doi: 10.1002/cncr.21219. Cancer. 2005. PMID: 15973667 Free article. Clinical Trial.

3

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.

Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G. Oki Y, et al. Blood. 2006 Feb 1;107(3):880-4. doi: 10.1182/blood-2005-06-2450. Epub 2005 Aug 25. Blood. 2006. PMID: 16123215 Free article.

4

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Fayad LE, Pro B, Mansfield PF, Clayman GL, Medeiros LJ, Kwak LW, Srivastava PK, Younes A. Oki Y, et al. Cancer. 2007 Jan 1;109(1):77-83. doi: 10.1002/cncr.22389. Cancer. 2007. PMID: 17133412 Free article.

5

Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.

Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A. Oki Y, et al. Haematologica. 2007 Feb;92(2):269-70. doi: 10.3324/haematol.10678. Haematologica. 2007. PMID: 17296586 Free article.

6

Elevated serum BLyS levels in patients with non-Hodgkin lymphoma.

Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A. Oki Y, et al. Leuk Lymphoma. 2007 Sep;48(9):1869-71. doi: 10.1080/10428190701549562. Leuk Lymphoma. 2007. PMID: 17786728 No abstract available.

7

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.

Oki Y, Pro B, Fayad LE, Romaguera J, Samaniego F, Hagemeister F, Neelapu S, McLaughlin P, Goy A, Younes A. Oki Y, et al. Cancer. 2008 Feb 15;112(4):831-6. doi: 10.1002/cncr.23237. Cancer. 2008. PMID: 18085611 Free article. Clinical Trial.

8

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y. Oki Y, et al. Eur J Haematol. 2008 Dec;81(6):448-53. doi: 10.1111/j.1600-0609.2008.01129.x. Epub 2008 Aug 6. Eur J Haematol. 2008. PMID: 18691256

9

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Wang M, Oki Y, Pro B, Romaguera JE, Rodriguez MA, Samaniego F, McLaughlin P, Hagemeister F, Neelapu S, Copeland A, Samuels BI, Loyer EM, Ji Y, Younes A. Wang M, et al. Among authors: oki y. J Clin Oncol. 2009 Nov 1;27(31):5213-8. doi: 10.1200/JCO.2009.21.8545. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770379 Clinical Trial.

10

Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.

Chihara D, Oki Y, Ine S, Kato H, Onoda H, Taji H, Kagami Y, Yamamoto K, Morishima Y. Chihara D, et al. Among authors: oki y. Eur J Haematol. 2010 Jun;84(6):493-8. doi: 10.1111/j.1600-0609.2010.01426.x. Epub 2010 Feb 9. Eur J Haematol. 2010. PMID: 20148943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

575 results

Search Page